Bussiness3 months ago
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Dyne Therapeutics, Inc. – Recent Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrated Compelling Impact on Key Disease...
